Document Detail


Oxytocin and tumor necrosis factor alpha stimulate expression of prostaglandin E2 synthase and secretion of prostaglandin E2 by luminal epithelial cells of the porcine endometrium during early pregnancy.
MedLine Citation:
PMID:  20616214     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Oxytocin (OXT) and tumor necrosis factor α (TNF) have been implicated in the control of luteolysis by stimulating endometrial secretion of luteolytic prostaglandin F(2α) (PGF(2α)). Nevertheless, OXT concentration in porcine uterine lumen increases markedly on days 11-12 of pregnancy, and TNF is expressed in endometrium during pregnancy. The objective of the study was to determine the effect of OXT and TNF on expression of the enzymes involved in PG synthesis: PG-endoperoxide synthase 2 (PTGS2), PGE(2) synthase (mPGES-1) and PGF synthase, and PGE(2) receptor (PTGER2), as well as on PG secretion by endometrial luminal epithelial cells (LECs) on days 11-12 of the estrous cycle and pregnancy. LECs isolated from gilts on days 11-12 of the estrous cycle (n=8) and pregnancy (n=7) were treated with OXT (100  nmol/l) and TNF (0.6  nmol/l) for 24  h. OXT increased PTGS2 mRNA and mPGES-1 protein contents, as well as PGE(2) secretion but only on days 11-12 of pregnancy. TNF stimulated PTGS2 and mPGES-1 mRNA, as well as mPGES-1 protein expression and PGE(2) release on days 11-12 of pregnancy and the estrous cycle. In addition, expressions of PTGER2 and PTGER4 were determined in corpus luteum (CL). Abundance of PTGER2 mRNA and PTGER4 protein in CL was upregulated on day 14 of pregnancy versus day 14 of the estrous cycle. This study indicates that TNF and OXT regulate PGE(2) synthesis in LECs during early pregnancy. PGE(2) secreted by LECs, after reaching ovaries, could have a luteoprotective effect through luteal PTGER2 and PTGER4, or may directly promote uterine function and conceptus development.
Authors:
Agnieszka Waclawik; Agnieszka Blitek; Adam J Ziecik
Related Documents :
3533874 - Interrelationships between uterus and conceptus to maintain corpus luteum function in e...
12169834 - Effect of intrauterine ischemia-hypoxia on endothelial nitric oxide synthase in fetal b...
8569234 - Pregnancy terminating effect of jatropha curcas in rats.
6955894 - Comparative studies of prostaglandins f2 alpha and e2 in late cyclic and early pregnant...
21409544 - Fetal mri clues to diagnose cloacal malformations.
15977444 - Experience of tubal surgery for infertility at the obafemi awolowo university teaching ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-07-08
Journal Detail:
Title:  Reproduction (Cambridge, England)     Volume:  140     ISSN:  1741-7899     ISO Abbreviation:  Reproduction     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-30     Completed Date:  2011-01-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100966036     Medline TA:  Reproduction     Country:  England    
Other Details:
Languages:  eng     Pagination:  613-22     Citation Subset:  IM    
Affiliation:
Institute of Animal Reproduction and Food Research of Polish Academy of Sciences, Olsztyn, Poland. waclawik@pan.olsztyn.pl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blotting, Western / veterinary
Dinoprostone / metabolism*,  secretion
Endometrium / drug effects*,  enzymology,  metabolism,  secretion
Epithelial Cells / drug effects,  metabolism
Estrous Cycle / metabolism
Female
Hydroxyprostaglandin Dehydrogenases / genetics,  metabolism
Immunoenzyme Techniques / veterinary
Intramolecular Oxidoreductases / biosynthesis*,  genetics,  metabolism
Oxytocin / pharmacology*
Pregnancy
Prostaglandin-Endoperoxide Synthases / genetics,  metabolism
RNA, Messenger / chemistry,  genetics
Receptors, Prostaglandin E / genetics,  metabolism
Reverse Transcriptase Polymerase Chain Reaction / veterinary
Swine / metabolism*
Tumor Necrosis Factor-alpha / pharmacology*
Chemical
Reg. No./Substance:
0/RNA, Messenger; 0/Receptors, Prostaglandin E; 0/Tumor Necrosis Factor-alpha; 363-24-6/Dinoprostone; 50-56-6/Oxytocin; EC 1.1.1.-/Hydroxyprostaglandin Dehydrogenases; EC 1.1.1.188/prostaglandin-F synthase; EC 1.14.99.1/Prostaglandin-Endoperoxide Synthases; EC 5.3.-/Intramolecular Oxidoreductases; EC 5.3.99.3/prostaglandin-E synthase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Craniofacial Changes after Two Years of nCPAP Use in Obstructive Sleep Apnea Patients.
Next Document:  Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro a...